{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T12:54:12Z","timestamp":1788267252537,"version":"build-2803163510"},"reference-count":60,"publisher":"Oxford University Press (OUP)","issue":"5","license":[{"start":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T00:00:00Z","timestamp":1770076800000},"content-version":"vor","delay-in-days":2712,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"},{"start":{"date-parts":[[2018,8,7]],"date-time":"2018-08-07T00:00:00Z","timestamp":1533600000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/100007825","name":"ACVIM Cardiology Pacemaker Grant","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007825","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007825","name":"American College of Veterinary Internal Medicine","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007825","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2018,9,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>The effects of sacubitril\/valsartan (S\/V) on the renin-angiotensin-aldosterone system (RAAS) in dogs with cardiomegaly secondary to myxomatous mitral valve disease (MMVD) are currently unknown.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>To determine the pharmacodynamic effects of S\/V on the RAAS, natriuretic peptide concentrations, systolic arterial pressure (SAP), tests of renal function, and serum electrolyte concentrations in dogs with cardiomegaly secondary to MMVD.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Animals<\/jats:title>\n                    <jats:p>Thirteen client-owned dogs weighing 4-15 kg with American College of Veterinary Internal Medicine (ACVIM) Stage B2 MMVD.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Prospective, randomized, double-blind, placebo-controlled pilot study of S\/V in dogs with ACVIM Stage B2 MMVD.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Thirteen dogs were recruited: S\/V (n\u2009=\u20097) and placebo (n\u2009=\u20096). The median percentage increase in urinary aldosterone to creatinine ratio (UAldo : C) between day 0 and day 30 was significantly lower in the S\/V group (12%; P\u2009=\u2009.032) as compared with the placebo group (195%). The median percentage decrease of NT-proBNP concentration from day 0 to day 30 was not statistically different between groups (P\u2009=\u2009.68). No statistical differences were seen in echocardiographic, thoracic radiographic, SAP, or serum biochemical test results measured at any time point between groups. No adverse events were observed for dogs in either group.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion and Clinical Importance<\/jats:title>\n                    <jats:p>Sacubitril\/valsartan may provide a new pharmaceutical method to effectively inhibit the RAAS in dogs with ACVIM Stage B2 MMVD.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1111\/jvim.15240","type":"journal-article","created":{"date-parts":[[2018,8,7]],"date-time":"2018-08-07T08:56:13Z","timestamp":1533632173000},"page":"1555-1563","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["A prospective, randomized, double-blind, placebo-controlled pilot study of sacubitril\/valsartan (Entresto) in dogs with cardiomegaly secondary to myxomatous mitral valve disease"],"prefix":"10.1093","volume":"32","author":[{"given":"Daniel K.","family":"Newhard","sequence":"first","affiliation":[{"name":"College of Veterinary Medicine, Auburn University Department of Clinical Sciences, , Auburn, Alabama"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6313-3084","authenticated-orcid":false,"given":"SeungWoo","family":"Jung","sequence":"additional","affiliation":[{"name":"College of Veterinary Medicine, Auburn University Department of Clinical Sciences, , Auburn, Alabama"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Randolph L.","family":"Winter","sequence":"additional","affiliation":[{"name":"College of Veterinary Medicine, Auburn University Department of Clinical Sciences, , Auburn, Alabama"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sue H.","family":"Duran","sequence":"additional","affiliation":[{"name":"College of Veterinary Medicine, Auburn University Department of Clinical Sciences, , Auburn, Alabama"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2018,9,1]]},"reference":[{"key":"2026020922031305600_jvim15240-bib-0001","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1161\/01.CIR.82.5.1730","article-title":"Hormones regulating cardiovascular function in patients with severe congestive heart failure and their relation to mortality. CONSENSUS Trial Study Group","volume":"82","author":"Swedberg","year":"1990","journal-title":"Circulation."},{"key":"2026020922031305600_jvim15240-bib-0002","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1093\/eurjhf\/hft100","article-title":"Serum aldosterone is associated with mortality and re-hospitalization in patients with reduced ejection fraction hospitalized for acute heart failure: Analysis from the EVEREST trial","volume":"15","author":"Girerd","year":"2013","journal-title":"Eur J Heart Fail."},{"key":"2026020922031305600_jvim15240-bib-0003","first-page":"24","article-title":"Relationships between serum and urinary aldosterone, ventricular remodeling and outcome in dogs with mitral valve disease. 2010 American College of Veterinary Internal Medicine (ACVIM) Forum Research Abstract Program","author":"Hezzell","year":"2010","journal-title":"JVet Intern Med"},{"key":"2026020922031305600_jvim15240-bib-0004","first-page":"1142","article-title":"Guidelines for the diagnosis and treatment of canine chronic valvular heart disease","volume":"23","author":"Atkins","year":"2009","journal-title":"JVet Intern Med."},{"key":"2026020922031305600_jvim15240-bib-0005","first-page":"93","article-title":"Comparison of some pharmacokinetic parameters of 5 angiotensin-converting enzyme inhibitors in normal beagles","volume":"12","author":"Hamlin","year":"1998","journal-title":"JVet Intern Med."},{"key":"2026020922031305600_jvim15240-bib-0006","doi-asserted-by":"crossref","first-page":"22348","DOI":"10.1016\/S0021-9258(18)45712-2","article-title":"Identification of a highly specific chymase as the major angiotensin II-forming enzyme in the human heart","volume":"265","author":"Urata","year":"1990","journal-title":"JBiol Chem."},{"key":"2026020922031305600_jvim15240-bib-0007","first-page":"H2065","article-title":"Increased ACE and chymase-like activity in cardiac tissue of dogs with chronic mitral regurgitation","volume":"269","author":"Dell'Italia","year":"1995","journal-title":"Am J Physiol."},{"key":"2026020922031305600_jvim15240-bib-0008","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1038\/ncpneph0575","article-title":"The incidence and implications of aldosterone breakthrough","volume":"3","author":"Bomback","year":"2007","journal-title":"Nat Clin Pract Nephrol."},{"key":"2026020922031305600_jvim15240-bib-0009","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1111\/jvp.12216","article-title":"The effect of enalapril on furosemide-activated renin-angiotensin-aldosterone system in healthy dogs","volume":"38","author":"Lantis","year":"2015","journal-title":"JVet Pharmacol Therap."},{"key":"2026020922031305600_jvim15240-bib-0010","first-page":"147032031663389","article-title":"Evaluation of subacute change in RAAS activity (as indicated by urinary aldosterone:creatinine, after pharmacologic provocation) and the response to ACE inhibition","volume":"17","author":"Ames","year":"2016","journal-title":"JRenin Angiotensin Aldosterone Syst."},{"key":"2026020922031305600_jvim15240-bib-0011","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1111\/jvp.12154","article-title":"Aldosterone breakthrough with benazepril in furosemide-activated renin-angiotensin-aldosterone system in normal dogs","volume":"38","author":"Lantis","year":"2015","journal-title":"JVet Pharmacol Therap."},{"key":"2026020922031305600_jvim15240-bib-0012","first-page":"218","article-title":"Aldosterone breakthrough in dogs with naturally occurring myxomatous mitral valve disease","volume":"19","author":"Ames","year":"2017","journal-title":"JVet Cardiol."},{"key":"2026020922031305600_jvim15240-bib-0013","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.2460\/ajvr.1996.57.11.1645","article-title":"Effects of long-term treatment with enalapril or hydralazine on the renin-angiotensin-aldosterone system and fluid balance in dogs with naturally acquired mitral valve regurgitation","volume":"57","author":"Haggstrom","year":"1996","journal-title":"Am J Vet Res."},{"key":"2026020922031305600_jvim15240-bib-0014","first-page":"248","article-title":"Evaluation of the effect of an angiotensin-converting enzyme inhibitor, alacepril, on drug-induced renin-angiotensin-aldosterone system activation in normal dogs","volume":"18","author":"Sakatani","year":"2016","journal-title":"JVet Cardiol."},{"key":"2026020922031305600_jvim15240-bib-0015","first-page":"331","article-title":"Efficacy of spironolactone on survival in dogs with naturally occurring mitral regurgitation caused by myxomatous mitral valve disease","volume":"24","author":"Bernay","year":"2010","journal-title":"JVet Intern Med."},{"key":"2026020922031305600_jvim15240-bib-0016","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1056\/NEJMoa010713","article-title":"A randomized trial of the angiotensin-receptor blocker valsartan in chronic heart failure","volume":"345","author":"Cohn","year":"2001","journal-title":"N Engl J Med."},{"key":"2026020922031305600_jvim15240-bib-0017","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/S0140-6736(97)01187-2","article-title":"Randomised trial of losartan versus captopril in patients over 65 with heart failure (Evaluation of Losartan in the Elderly Study, ELITE)","volume":"349","author":"Pitt","year":"1997","journal-title":"Lancet."},{"key":"2026020922031305600_jvim15240-bib-0018","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/j.jash.2012.07.003","article-title":"Aldosterone breakthrough during aliskiren, valsartan, and combination (aliskiren\u2009+\u2009valsartan) therapy","volume":"6","author":"Bomback","year":"2012","journal-title":"JAm Soc Hypertens."},{"key":"2026020922031305600_jvim15240-bib-0019","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1016\/j.ijcard.2014.08.032","article-title":"Natriuretic peptides and cardio-renal disease","volume":"176","author":"Volpe","year":"2014","journal-title":"Int J Cardiol."},{"key":"2026020922031305600_jvim15240-bib-0020","first-page":"S9","article-title":"The evolution of the natriuretic peptides - Current applications in human and animal medicine","volume":"11","author":"van Kimmenade","year":"2009","journal-title":"JVet Cardiol."},{"key":"2026020922031305600_jvim15240-bib-0021","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/j.cvsm.2010.03.004","article-title":"The use of NT-proBNP assay in the management of canine patients with heart disease","volume":"40","author":"Oyama","year":"2010","journal-title":"Vet Clin North Am Small Anim Pract."},{"key":"2026020922031305600_jvim15240-bib-0022","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/j.jacc.2014.11.048","article-title":"Soluble neprilysin is predictive of cardiovascular death and heart failure hospitalization in heart failure patients","volume":"65","author":"Bayes-Genis","year":"2015","journal-title":"JAm Coll Cardiol."},{"key":"2026020922031305600_jvim15240-bib-0023","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/j.amjcard.2005.05.032","article-title":"Lower rather than higher levels of B-type natriuretic peptides (NT-pro-BNP and BNP) predict short-term mortality in end-stage heart failure patients treated with nesiritide","volume":"96","author":"Miller","year":"2005","journal-title":"Am J Cardiol."},{"key":"2026020922031305600_jvim15240-bib-0024","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1056\/NEJMoa1409077","article-title":"Angiotensin-neprilysin inhibition versus enalapril in heart failure","volume":"371","author":"McMurray","year":"2014","journal-title":"N Engl J Med."},{"key":"2026020922031305600_jvim15240-bib-0025","doi-asserted-by":"crossref","first-page":"A806","DOI":"10.1016\/S0735-1097(14)60806-8","article-title":"First-in-class angiotensin receptor neprilysin inhibitor LCZ696 modulates the dynamics of the renin cascade and natriuretic peptides system with significant reduction of aldosterone exposure [abstract]","volume":"63 Suppl 1","author":"Mochel","year":"2014","journal-title":"JAm Coll Cardiol."},{"key":"2026020922031305600_jvim15240-bib-0026","first-page":"429","article-title":"Evaluation of four 2-dimensional echocardiographic methods of assessing left atrial size in dogs","volume":"14","author":"Rishniw","year":"2000","journal-title":"JVet Intern Med."},{"key":"2026020922031305600_jvim15240-bib-0027","first-page":"311","article-title":"Allometric scaling of M-mode cardiac measurements in normal adult dogs","volume":"18","author":"Cornell","year":"2004","journal-title":"JVet Intern Med."},{"key":"2026020922031305600_jvim15240-bib-0028","doi-asserted-by":"crossref","first-page":"194","DOI":"10.2460\/javma.1995.206.02.194","article-title":"Vertebral scale system to measure canine heart size in radiographs","volume":"206","author":"Buchanan","year":"1995","journal-title":"JAm Vet Med Assoc."},{"key":"2026020922031305600_jvim15240-bib-0029","first-page":"1765","article-title":"Effect of Pimobendan in Dogs with Preclinical Myxomatous Mitral Valve Disease and Cardiomegaly: The EPIC Study-A Randomized Clinical Trial","volume":"30","author":"Boswood","year":"2016","journal-title":"JVet Intern Med."},{"key":"2026020922031305600_jvim15240-bib-0030","doi-asserted-by":"crossref","first-page":"617","DOI":"10.2217\/fca-2016-0026","article-title":"A randomized double-blind placebo-controlled crossover trial of sodium nitrate in patients with stable angina INAS","volume":"12","author":"Schwarz","year":"2016","journal-title":"Future Cardiol"},{"key":"2026020922031305600_jvim15240-bib-0031","doi-asserted-by":"crossref","first-page":"715","DOI":"10.3109\/07420528.2014.897711","article-title":"Influence of feeding schedules on the chronobiology of renin activity, urinary electrolytes and blood pressure in dogs","volume":"31","author":"Mochel","year":"2014","journal-title":"Chronobiol Int."},{"key":"2026020922031305600_jvim15240-bib-0032","first-page":"542","article-title":"Guidelines for the identification, evaluation, and management of systemic hypertension in dogs and cats","volume":"21","author":"Brown","year":"2007","journal-title":"JVet Intern Med."},{"key":"2026020922031305600_jvim15240-bib-0033","first-page":"247","article-title":"Recommendations for standards in transthoracic two-dimensional echocardiography in the dog and cat. Echocardiography Committee of the Specialty of Cardiology, American College of Veterinary Internal Medicine","volume":"7","author":"Thomas","year":"1993","journal-title":"JVet Intern Med."},{"key":"2026020922031305600_jvim15240-bib-0034","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1111\/j.1751-0813.2000.tb10361.x","article-title":"Echocardiographic measurements in greyhounds, whippets and Italian greyhounds\u2013dogs with a similar conformation but different size","volume":"78","author":"della Torre","year":"2000","journal-title":"Aust Vet J."},{"key":"2026020922031305600_jvim15240-bib-0035","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1172\/JCI105543","article-title":"Postural augmentation of plasma renin activity and aldosterone excretion in normal people","volume":"46","author":"Cohen","year":"1967","journal-title":"JClin Invest."},{"key":"2026020922031305600_jvim15240-bib-0036","first-page":"1","article-title":"Estimation of 24-h aldosterone secretion in the dog using the urine aldosterone:creatinine ratio","volume":"9","author":"Gardner","year":"2007","journal-title":"JVet Cardiol."},{"key":"2026020922031305600_jvim15240-bib-0037","first-page":"569","article-title":"Prevalence and prognostic importance of pulmonary hypertension in dogs with myxomatous mitral valve disease","volume":"29","author":"Borgarelli","year":"2015","journal-title":"JVet Intern Med."},{"key":"2026020922031305600_jvim15240-bib-0038","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1111\/jvp.12011","article-title":"Utility of urinary aldosterone measurement in quantitating RAAS activation","volume":"35","author":"Atkins","year":"2012","journal-title":"JVet Pharmacol Ther."},{"key":"2026020922031305600_jvim15240-bib-0039","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1016\/S0735-1097(02)01763-1","article-title":"Angiotensin II receptor blockade does not improve left ventricular function and remodeling in subacute mitral regurgitation in the dog","volume":"39","author":"Perry","year":"2002","journal-title":"JAm Coll Cardiol."},{"key":"2026020922031305600_jvim15240-bib-0040","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1111\/j.1523-1755.2005.00269.x","article-title":"Natriuretic and antialdosterone actions of chronic oral NEP inhibition during progressive congestive heart failure","volume":"67","author":"Martin","year":"2005","journal-title":"Kidney Int."},{"key":"2026020922031305600_jvim15240-bib-0041","doi-asserted-by":"crossref","first-page":"2425","DOI":"10.1016\/j.jacc.2016.09.931","article-title":"Prognostic Implications of Changes in N-Terminal Pro-B-Type Natriuretic Peptide in Patients With Heart Failure","volume":"68","author":"Zile","year":"2016","journal-title":"JAm Coll Cardiol."},{"key":"2026020922031305600_jvim15240-bib-0042","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1016\/S0140-6736(12)61227-6","article-title":"The angiotensin receptor neprilysin inhibitor LCZ696 in heart failure with preserved ejection fraction: a phase 2 double-blind randomised controlled trial","volume":"380","author":"Solomon","year":"2012","journal-title":"Lancet."},{"key":"2026020922031305600_jvim15240-bib-0043","first-page":"124","article-title":"Biologic variability of N-terminal pro-brain natriuretic peptide in healthy dogs and dogs with myxomatous mitral valve disease","volume":"19","author":"Winter","year":"2017","journal-title":"JVet Cardiol."},{"key":"2026020922031305600_jvim15240-bib-0044","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.tvjl.2012.06.019","article-title":"Possible mechanisms for brain natriuretic peptide resistance in heart failure with a focus on interspecies differences and canine BNP biology","volume":"194","author":"Baerts","year":"2012","journal-title":"Vet J."},{"key":"2026020922031305600_jvim15240-bib-0045","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1161\/01.CIR.0000124064.00494.21","article-title":"Brain natriuretic peptide enhances renal actions of furosemide and suppresses furosemide-induced aldosterone activation in experimental heart failure","volume":"109","author":"Cataliotti","year":"2004","journal-title":"Circulation."},{"key":"2026020922031305600_jvim15240-bib-0046","first-page":"1190","article-title":"Evaluation of pimobendan and N-terminal probrain natriuretic peptide in the treatment of pulmonary hypertension secondary to degenerative mitral valve disease in dogs","volume":"23","author":"Atkinson","year":"2009","journal-title":"JVet Intern Med."},{"key":"2026020922031305600_jvim15240-bib-0047","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1016\/S0140-6736(09)61966-8","article-title":"Blood-pressure reduction with LCZ696, a novel dual-acting inhibitor of the angiotensin II receptor and neprilysin: A randomised, double-blind, placebo-controlled, active comparator study","volume":"375","author":"Ruilope","year":"2010","journal-title":"Lancet."},{"key":"2026020922031305600_jvim15240-bib-0048","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1161\/HYPERTENSIONAHA.113.02002","article-title":"Efficacy and safety of LCZ696, a first-in-class angiotensin receptor neprilysin inhibitor, in Asian patients with hypertension: A randomized, double-blind, placebo-controlled study","volume":"63","author":"Kario","year":"2014","journal-title":"Hypertension"},{"key":"2026020922031305600_jvim15240-bib-0049","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1161\/01.CIR.0000029801.86489.50","article-title":"Comparison of omapatrilat and enalapril in patients with chronic heart failure: the Omapatrilat Versus Enalapril Randomized Trial of Utility in Reducing Events (OVERTURE)","volume":"106","author":"Packer","year":"2002","journal-title":"Circulation"},{"key":"2026020922031305600_jvim15240-bib-0050","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.ijcard.2014.11.059","article-title":"Neprilysin inhibitors preserve renal function in heart failure","volume":"179","author":"Bodey","year":"2015","journal-title":"Int J Cardiol."},{"key":"2026020922031305600_jvim15240-bib-0051","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/0024-3205(89)90287-7","article-title":"Increased serum levels of endopeptidase 24.11 ('enkephalinase') in patients with end-stage renal failure","volume":"45","author":"Deschodt-Lanckman","year":"1989","journal-title":"Life Sci."},{"key":"2026020922031305600_jvim15240-bib-0052","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1111\/jsap.12387","article-title":"Cardiovascular-renal axis disorders in the domestic dog and cat: a veterinary consensus statement","volume":"56","author":"Pouchelon","year":"2015","journal-title":"JSmall Anim Pract."},{"issue":"5","key":"2026020922031305600_jvim15240-bib-0053","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1111\/bcp.13505","article-title":"Effect of the angiotensin receptor neprilysin inhibitor sacubitril\/valsartan on pharmacokinetics and pharmacodynamics of a single-dose of furosemide","volume":"84","author":"Ayalasomayajula","year":"2018","journal-title":"Br J Clin Pharmacol."},{"key":"2026020922031305600_jvim15240-bib-0054","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1097\/JCN.0000000000000451","article-title":"From Theory to Practice: The Diuretic Potential of Sacubitril\/Valsartan: A Tale of 2 Patients","volume":"33","author":"Hormann","year":"2018","journal-title":"JCardiovasc Nurs."},{"key":"2026020922031305600_jvim15240-bib-0055","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.3109\/07420528.2013.807275","article-title":"Chronobiology of the renin-angiotensin-aldosterone system in dogs: Relation to blood pressure and renal physiology","volume":"30","author":"Mochel","year":"2013","journal-title":"Chronobiol Int."},{"key":"2026020922031305600_jvim15240-bib-0056","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/112_2015_27","article-title":"Chronobiology and pharmacologic modulation of the renin-angiotensin-aldosterone system in dogs: What have we learned?","volume":"169","author":"Mochel","year":"2015","journal-title":"Rev Physiol Biochem Pharmacol."},{"key":"2026020922031305600_jvim15240-bib-0057","doi-asserted-by":"crossref","first-page":"77","DOI":"10.2460\/ajvr.1997.58.01.77","article-title":"Effects of naturally acquired decompensated mitral valve regurgitation on the renin-angiotensin-aldosterone system and atrial natriuretic peptide concentration in dogs","volume":"58","author":"Haggstrom","year":"1997","journal-title":"Am J Vet Res."},{"key":"2026020922031305600_jvim15240-bib-0058","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/j.1748-5827.2009.00801.x","article-title":"Neurohormonal activation in canine degenerative mitral valve disease: implications on pathophysiology and treatment","volume":"50","author":"Oyama","year":"2009","journal-title":"JSmall Anim Pract."},{"key":"2026020922031305600_jvim15240-bib-0059","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.2460\/ajvr.68.10.1045","article-title":"Modulation of the tissue reninangiotensin-aldosterone system in dogs with chronic mild regurgitation through the mitral valve","volume":"68","author":"Fujii","year":"2007","journal-title":"Am J Vet Res."},{"key":"2026020922031305600_jvim15240-bib-0060","first-page":"1003","article-title":"Acute effect of pimobendan and furosemide on the circulating renin-angiotensin-aldosterone system in healthy dogs","volume":"23","author":"Sayer","year":"2009","journal-title":"JVet Intern Med."}],"container-title":["Journal of Veterinary Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fjvim.15240","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/jvim\/article-pdf\/32\/5\/1555\/66670047\/jvim15240.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jvim\/article-pdf\/32\/5\/1555\/66670047\/jvim15240.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T03:04:26Z","timestamp":1770692666000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jvim\/article\/32\/5\/1555\/8449580"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9,1]]},"references-count":60,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2018,9,1]]}},"URL":"https:\/\/doi.org\/10.1111\/jvim.15240","relation":{},"ISSN":["1939-1676"],"issn-type":[{"value":"1939-1676","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2018,9]]},"published":{"date-parts":[[2018,9,1]]},"assertion":[{"value":"2018-02-15","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-05-16","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-08-07","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}